Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Common Equity (2016 - 2025)

Solesence (SLSN) has disclosed Common Equity for 16 consecutive years, with $17.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity rose 13.57% year-over-year to $17.2 million, compared with a TTM value of $17.2 million through Sep 2025, up 13.57%, and an annual FY2024 reading of $14.9 million, up 685.8% over the prior year.
  • Common Equity was $17.2 million for Q3 2025 at Solesence, down from $18.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $18.2 million in Q2 2025 and bottomed at $1.9 million in Q4 2023.
  • Average Common Equity over 5 years is $8.8 million, with a median of $7.5 million recorded in 2021.
  • The sharpest move saw Common Equity tumbled 66.33% in 2023, then surged 685.8% in 2024.
  • Year by year, Common Equity stood at $7.5 million in 2021, then fell by 24.33% to $5.6 million in 2022, then plummeted by 66.33% to $1.9 million in 2023, then soared by 685.8% to $14.9 million in 2024, then grew by 15.26% to $17.2 million in 2025.
  • Business Quant data shows Common Equity for SLSN at $17.2 million in Q3 2025, $18.2 million in Q2 2025, and $15.2 million in Q1 2025.